 Sir from here it's over to you. Thank you Priyank. Good morning to all of you. I won't say good morning, good afternoon, good evening. That is for Dr Plump to say that. So welcome to the 15th edition of USAICs. This has been a tough time for all of us like we met in September for a virtual meeting and here we are in June 22nd and still we are going through the COVID. People have survived the first wave, the second wave and I was in India in April and it was pretty I would say bad situation like you know we all watched on TV here in the US and Europe over there but it was really heartbreaking and I think the entire system was totally or totally overwhelmed you know what was going on over there. The good thing is you know when I came back here in the beginning of May there was such a tremendous amount of support and assistance from the US biopharma companies the large and even the startups was getting almost about a couple of calls per day even so startups they wanted to give their you know testing equipment and the kits and the PPE so and tons of money has been given as assistance over there. This shows the real heart of this industry. A lot of lives which could have been saved had gone. People have survived this first and the second wave. I think we have to make sure that there is no third wave and if it is there we don't have this kind of disastrous effects over there. So I really want to thank you know all the big biopharma companies which came together, Pfizer or Mgene or Biogen, Takeda, Sanofi, Janssen and all of them and even Indujals and they never want to talk about you know how much they've given. In fact I have a good friend in the media and he wanted to do a story like how much money has gone in and I know how much they've given but look at the heart of this you know generous people they never wanted people to discuss it how much they've given because they did what was right and that is what our industry is for. The patient-driven kind want to save lives and work for the innovation for the global mankind over there. We have a couple of thousand people which have registered today. We made it free in this situation for COVID worldwide. It's a great lineup and glad to say that over one and a half thousand 1500 students have registered all over the world including from India and they are watching it live. So these are the future leaders who will do innovation and R&D and help patients with new discoveries over there. I also want to thank all the sponsors because I thank all the big you know pharma and the biotech which helped India in this crisis. So I shouldn't miss any name so I'll talk start with Akon, AI, Alexion, Amgen, Baikon, Biogen, Janssen, Jubilant, Merck, Sunfarman and Takita. Thank you so much all of you. Access and equity are you know pretty much in discussion for the last 15 years and not so much that it's come to this and now in the last year or so and you'll be hearing about it today in the entire discussion. So I want to thank everybody.